About: Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1993 (uk) article scientifique publié en 1993 (fr) im November 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 1993 (ast) scientific article published on 01 November 1993 (en)
publication date	wds:Q72559262-EBF8540E-31F5-4199-B6DE-1E263F823523
publication date	1993-11-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72559262-0E2B7BC8-68FA-4F4D-A5A3-E055AF10489E
language of work or name	English
author name string	wds:Q72559262-3060B8B1-6B33-44A9-A4C8-EE838CACBBED wds:Q72559262-3F420324-481D-48B6-9FF3-0A6AADC74B2F wds:Q72559262-446985AC-B1C5-41FB-B575-F3FCC7536961 wds:Q72559262-8BDD92B6-7CE4-4FBB-8889-830775431528 wds:Q72559262-B9F4BB9B-178A-4EA0-98D8-FEACC93718FA wds:Q72559262-D0F58645-2411-47F5-844B-E4DCF23DFF02 wds:Q72559262-EB898514-DF3A-433D-852A-E0D549CB25C2
author name string	Y Tao A N Houghton P B Chapman D F Bajorin G Y Wong M A Templeton M N Sirott
rdfs:label	Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis (en) Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis (nl)
skos:prefLabel	Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis (en) Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis (nl)
name	Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis (en) Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis (nl)
title	wds:Q72559262-FBBF98AC-C94F-41D0-A080-828E4F95DD97
title	Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis (en)
page(s)	wds:Q72559262-6C2D7FCC-EB29-4198-9CD1-FE3850E60978
page(s)	3091-3098
instance of	wds:Q72559262-7863D919-A86E-4531-95A9-8B85AA125AAF
instance of	scholarly article
main subject	wds:Q72559262-6D26973A-8AC0-4C42-A58A-07AFC68E9C3B
main subject	multivariate statistics
PubMed ID	wds:Q72559262-7F1D25E6-3F0E-4CB9-8FF6-934CC22F4980
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8221576
PubMed ID	8221576
published in	wds:Q72559262-F545ACE0-ECB0-4CF8-82AB-A4C9241153AF
published in	Cancer
issue	wds:Q72559262-75EBF1AF-100B-4541-97F1-D16ACDE88EBA
volume	wds:Q72559262-A0DF2EEE-821C-41B9-9E16-EA813C113614
issue	10
volume	72
DOI	wds:Q72559262-0EA93572-6CFB-4E77-8B1F-B42BE3351F7D
DOI	http://dx.doi.org/10.1002/1097-0142(19931115)72:10%3C3091::AID-CNCR2820721034%3E3.0.CO;2-V
DOI	10.1002/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72559262
is cites work of	A prognostic model and staging for metastatic uveal melanoma. Prolonged survival after complete resection of metastases from intraocular melanoma Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease Prognostic factors and outcomes in patients with leptomeningeal melanomatosis Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Determinants of survival in patients with brain metastases from cutaneous melanoma NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Intervention of carbohydrate recognition by proteins and nucleic acids Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials A standardization method to adjust for the effect of patient selection in phase II clinical trials. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial Androgen blockade enhances response to melanoma vaccine A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response Melanoma biomarkers: Vox clamantis in deserto (Review) Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy Favorable prognostic factors in recurrent and metastatic melanoma Staging and prognosis of cutaneous melanoma Elevated serum levels of S100 and survival in metastatic malignant melanoma The changing prognosis of melanoma Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients Tumor-platelet interaction in solid tumors Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins S-100B concentrations predict disease-free survival in stage III melanoma patients Established and Emerging Biomarkers in Cutaneous Malignant Melanoma The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study. Diagnostic and prognostic biomarkers in melanoma WNT-5A: signaling and functions in health and disease The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy? Classification and staging of melanoma Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer Cancer outlook: an African perspective Highly sensitive detection of melanoma based on serum proteomic profiling.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software